José Antonio
Oteo Revuelta
Publicaciones en las que colabora con José Antonio Oteo Revuelta (3)
2021
2014
-
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1903-1910
2013
-
Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
PLoS ONE, Vol. 8, Núm. 1